How a New Boston Biotech Plans to Halt Diseases Before They Even Start
Etiome, a biotech startup, secured a $50 million investment from Flagship Pioneering to transform healthcare by intercepting diseases before symptoms arise. Utilizing multiomics data, artificial intelligence, and electronic health records,…